2025 · 4th Quarter (Oct 1 - Dec 31)

PERSONALIZED MEDICINE COALITION

Filed by PERSONALIZED MEDICINE COALITION.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 16, 2026
Income: Not reported
Expenses: $37,000.00
Registrant: PERSONALIZED MEDICINE COALITION
Client: PERSONALIZED MEDICINE COALITION
Filing UUID: 5461fffe-61fc-4dd1-a9a0-b96176c27645
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Congressional Personalized Medicine Caucus Genetic Testing and Genomic Sequencing for Rare Diseases H.R. 2471 Right Drug Dose Now Act H.R. 6208/S. 3607 Access to Genetic Counseling Services Act H.R. 3514 / S. 1816 Improving Seniors Timely Access to Care Act H.R. 5269/S. 2761Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act H.R. 1672 Maintaining Investments in New Innovation Act S. 832 Ensuring Pathways to Innovative Cures Act of 2025 Implementation of the Medicare Drug Price Negotiation (Public Law 117-169) Implementation of Rural Health Transformation Program (Public Law 119-21) Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community

Literal federal measure citations: H.R. 2471, H.R. 6208, S. 3607, H.R. 3514, S. 1816, H.R. 5269, H.R. 1672, S. 832

BUD · Budget/Appropriations

FY 2026 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2026 National Institutes of Health Budget Priorities Reauthorization of the Prescription Drug User Fee Act; PFUFA VIII Reauthorization of the Medical Device User Fee Act; MDUFA VI

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.